Abstract: The present invention relates to a dustbin. A dustbin of adjustable height, comprises: an outside container body and an inside container body, a compression spring provided between the bottom of outside container body and the bottom of inside container body, a longitudinal row of grooves provided at the side wall of inside container body, a level regulator provided at the side wall of outside container body, with its left end embeds in the groove and its right end coupling with a switch means to control the horizontal motion of the level regulator. According to the present invention, the level regulator catches in the groove at different heights so that the inside container body can project the outside container body. The height of inside container body can be adjusted to satisfy the users of different heights. The operation is very simple: to adjust the height, just press the manual button of the switch means.

Abstract: The present invention relates to Trash field. More particularly, the present invention relates to Trash can lid. The present invention provides a design of a big lid and a small lid. When an inhabitant usually disposes trash, he or she need only press a button to open the small lid. Since the small lid is connected with the big lid by magnetism and a spring buffer unit is installed in the seat of small lid, opening the small lid is very smooth, without any noise or vibration. When a dustman collects the trash, what he needs to do is only to open the big lid, being very convenient and sanitary.

Abstract: Stable liquid pharmaceutical compositions comprising an antagonist anti-CD40 antibody as a therapeutically or prophylactically active component and methods useful in their preparation are provided. These compositions comprise the antagonist anti-CD40 antibody, a buffering agent to maintain the pH of the composition between about pH 5.0 and about pH 7.0, and an amount of arginine-HCl sufficient to render the liquid composition near isotonic. The stable liquid antagonist anti-CD40 antibody-containing pharmaceutical compositions of the invention find use in methods for treating proliferative diseases and diseases having an autoimmune and/or inflammatory component.

Abstract: The invention generally describes a system and method for data backup and recovery, in particular for backing up an entire server (i.e., system state and data) in substantially real-time. The invention provides high availability by failing a source server over to a target server if the source server fails, where the target server is reconfigured nearly identically to the source server. The invention does not require the source and target servers to have identical hardware or operating system versions. The invention further allows for rapid, automatic, restoration of a source server.

Abstract: Compositions and methods of therapy for treating diseases mediated by stimulation of CD40 signaling on CD40-expressing cells are provided. The methods comprise administering a therapeutically effective amount of an antagonist anti-CD40 antibody or antigen-binding fragment thereof to a patient in need thereof. The antagonist anti-CD40 antibody or antigen-binding fragment thereof is free of significant agonist activity, but exhibits antagonist activity when the antibody binds a CD40 antigen on a human CD40-expressing cell. Antagonist activity of the anti-CD40 antibody or antigen-binding fragment thereof beneficially inhibits proliferation and/or differentiation of human CD40-expressing cells, such as B cells.

Abstract: Methods of therapy for treating diseases mediated by stimulation of CD40 signaling on CD40-expressing cells are provided. The methods comprise administering a therapeutically effective amount of an antagonist anti-CD40 antibody or antigen-binding fragment thereof to a patient in need thereof. The antagonist anti-CD40 antibody or antigen-binding fragment thereof is free of significant agonist activity, but exhibits antagonist activity when the antibody binds a CD40 antigen on a human CD40-expressing cell. Antagonist activity of the anti-CD40 antibody or antigen-binding fragment thereof beneficially inhibits proliferation and/or differentiation of human CD40 expressing cells, such as B cells.